Exosome Characterization and Analytical Development Summit
Evvnt Promotion / evvnt
Archivio
23.04.2024 - 25.04.2024 The Westin Boston Seaport District, 425 Summer Street, 02210 Boston, Massachusetts, USA
Time: 9:00 AM - 4:45 PM
Temi della conferenza
In the ever-evolving exosome field, the past year has witnessed remarkable progress. From Kimera's FDA IND approval to Brexogen's recent deal with HK inno.N and advancements in analytical technology, the landscape is rapidly advancing. Developing robust techniques is increasingly crucial, serving as the cornerstone for exosome therapeutics, alongside drug delivery applications and advancements.
In the ever-evolving exosome field, the past year has witnessed remarkable progress. From Kimera's FDA IND approval to Brexogen's recent deal with HK inno.N and advancements in analytical technology, the landscape is rapidly advancing. Developing robust techniques is increasingly crucial, serving as the cornerstone for exosome therapeutics, alongside drug delivery applications and advancements.
Professional congress organizer (PCO)
Hanson Wade
Hanson Wade
Annotazioni
URL:
Brochure: https://go.evvnt.com/2172701-3?pid=4832
Speakers: Brittany Mihelich, Principal Scientist, Astellas, Bruce Werber, Chief Executive Officer, BioXTek, Carla Mazzeo, Director of Research Development, AT Venture Center, and more
URL:
Brochure: https://go.evvnt.com/2172701-3?pid=4832
Speakers: Brittany Mihelich, Principal Scientist, Astellas, Bruce Werber, Chief Executive Officer, BioXTek, Carla Mazzeo, Director of Research Development, AT Venture Center, and more
Informazioni ed Iscrizioni:
https://go.evvnt.com/2172701-2?pid=4832
Ms. Jasmine Fletcher
Medicina General
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."
